Rethinking Memory Loss: New Dementia Type, LATE, Challenges Alzheimer's Dominance

Brain pathways, healthy versus fragmented, illustrating memory loss.
News
Admin .

Doctors are increasingly recognizing a distinct form of dementia, LATE (limbic-predominant age-related TDP-43 encephalopathy), which accounts for up to 20% of dementia cases. This condition, officially defined in 2019, presents with symptoms similar to Alzheimer's but progresses differently, prompting a re-evaluation of how memory loss is understood and diagnosed.

Key Takeaways

  • LATE dementia affects an estimated 15-20% of all dementia cases, particularly in individuals over 85.
  • It is characterized by progressive memory loss, especially difficulty recalling recent events (episodic memory).
  • Unlike Alzheimer's, LATE typically progresses more slowly and may initially focus more narrowly on memory issues.
  • Diagnosis is becoming more refined through cognitive testing and biomarker evidence, distinguishing it from Alzheimer's.
  • Understanding LATE is crucial for tailoring treatment and improving prognostic accuracy.

Understanding LATE Dementia

LATE, short for limbic-predominant age-related TDP-43 encephalopathy, is a newly recognized condition that can mimic Alzheimer's disease. It is caused by the accumulation of a protein called TDP-43 within brain cells, primarily affecting the limbic system, which is crucial for memory formation. While Alzheimer's is characterized by amyloid-beta plaques and tau tangles, LATE is defined by TDP-43 pathology.

Symptoms and Progression

The hallmark symptom of LATE is progressive memory loss, particularly affecting the ability to recall recent events. As the disease advances, language difficulties, such as word-finding problems, can emerge. Subtle behavioral changes, like disinhibition, may also occur. A key differentiator from Alzheimer's is the tempo of progression; LATE typically develops later in life, often in the late 70s and 80s, and tends to advance more slowly. Many individuals experience years of isolated memory loss before other cognitive functions are significantly impacted.

Distinguishing LATE from Alzheimer's and Normal Aging

Distinguishing LATE from normal age-related forgetfulness and Alzheimer's disease is critical. In normal aging, memory retrieval may slow, but the memory itself is usually intact. In both LATE and Alzheimer's, the memory trace can be lost. However, Alzheimer's tends to spread more rapidly through various brain networks, affecting planning, problem-solving, and spatial awareness alongside memory. LATE often remains more narrowly focused on memory for a longer period.

Diagnosis and Treatment

Historically, LATE could only be confirmed post-mortem. However, clinicians can now make a strong suspicion of LATE during life by combining cognitive testing with biomarker evidence. If Alzheimer's-specific biomarkers (amyloid or tau) are negative in someone with Alzheimer's-like symptoms, LATE becomes a leading possibility. While there are no treatments specifically targeting TDP-43 in LATE, older Alzheimer's medications that boost acetylcholine may offer some benefit. Identifying LATE is crucial because newer Alzheimer's drugs targeting amyloid are unlikely to benefit LATE patients. Accurate diagnosis also aids in clinical trials and public health planning as populations age.

The Role of Behavioral Changes

Emerging research suggests that dementia, including LATE, may not always begin with memory loss. Subtle changes in personality, such as apathy, irritability, impulsiveness, or loss of empathy, can be early indicators. This concept, known as Mild Behavioral Impairment (MBI), refers to new, sustained alterations in personality that can forecast cognitive decline. These behavioral shifts can signal underlying biological processes affecting brain regions that regulate emotion and motivation, sometimes preceding memory faltering.

Sources

Share: